As I’m sure you all know, the third conference on Strategies for Engineered Negligible Senesence (SENS3) is underway; a full schedule of presentations on rejuvenation, aging and longevity research research for those attending.

The purpose of the SENS conference series, like all the SENS initiatives (such as the journal Rejuvenation Research and the Methuselah Mouse Prize), is to expedite the development of truly effective therapies to postpone and treat human aging by tackling it as an engineering problem: not seeking elusive and probably illusory magic bullets, but instead enumerating the accumulating molecular and cellular changes that eventually kill us and identifying ways to repair — reverse — those changes, rather than merely to slow down their further accumulation.

Methuselah Foundation COO David Chambers has once again provided us with pictures of longevity-minded scientists in their natural habitat: between presentations, catching up on news and discussing prospects for the future. As for SENS2, it’s quite a crowd – to go along with the impressive list of abstracts and talks.